Efficiency associated with Epidermal growth factor receptor As well as Bevacizumab versus Osimertinib inside Sufferers With EGFR T790M-Mutated Non-Small Mobile or portable United states In the past Treated With Epidermis Growth Aspect Receptor-Tyrosine Kinase Inhibitor: Western The japanese Oncology Party 8715L Period Only two Randomized Medical study | #sotorasib #olaparib #epidermal growth factor receptor